MRSA Notes

MRSA Notes header image 2

Perestane – A New Hospital Grade Disinfectant

November 30th, 2006 · 2 Comments

solvaySolvay, an international chemical and pharmaceutical group located in Brussels, has developed a biocidal product, Perestane, that is an effective disinfectant against MRSA and C. difficile.

Perestane®, which Solvay is marketing presently in the European Union, is a disinfectant based on peracid chemistry with a range of potential applications in the public and domestic health domains (for instance: disinfection of medical instruments, superior quality household products, etc.). This very low odor biocide possesses all the qualities of some other peracid compounds – such as high disinfectant efficacy even with short contact times and a low impact on the environment – without the drawbacks of a strong pungent smell. In addition, it can demonstrate much lower corrosion rates against some of the materials frequently encountered in hospitals when compared to other oxidizing biocides.

“With Perestane®, Solvay has developed an innovative highly efficient, user- and environment-friendly disinfectant that can be implemented in various demanding applications,” said Eric Mignonat, Solvay’s General Manager for Peroxide business. “Through our chemical research and know-how, we have also succeeded in providing a workable solution for an emerging, life-threatening problem. We can help to make hospitals safer places to be,” added Eric Mignonat. Source

Perestane is currently only being marketed in the European Union.

Technorati , , ,

Tags: HA-MRSA · Infection Prevention · MRSA · Research and Development

2 responses so far ↓

Leave a Comment

Close
E-mail It